Schroder Investment Management Group decreased its holdings in Cigna Group (NYSE:CI – Free Report) by 62.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 124,620 shares of the health services provider’s stock after selling 204,820 shares during the quarter. Schroder Investment Management Group’s holdings in Cigna Group were worth $41,197,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of the business. Skandinaviska Enskilda Banken AB publ increased its holdings in shares of Cigna Group by 31.7% during the second quarter. Skandinaviska Enskilda Banken AB publ now owns 228,316 shares of the health services provider’s stock worth $75,477,000 after purchasing an additional 54,948 shares during the period. Colonial Trust Advisors grew its position in Cigna Group by 6.3% during the second quarter. Colonial Trust Advisors now owns 6,743 shares of the health services provider’s stock worth $2,229,000 after buying an additional 400 shares in the last quarter. Norges Bank bought a new position in Cigna Group during the 2nd quarter worth $1,110,426,000. Level Four Advisory Services LLC raised its holdings in Cigna Group by 3.2% in the 2nd quarter. Level Four Advisory Services LLC now owns 2,390 shares of the health services provider’s stock valued at $790,000 after acquiring an additional 74 shares in the last quarter. Finally, Korea Investment CORP raised its holdings in Cigna Group by 2.2% in the 2nd quarter. Korea Investment CORP now owns 199,405 shares of the health services provider’s stock valued at $65,919,000 after acquiring an additional 4,379 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.
Insider Transactions at Cigna Group
In other Cigna Group news, CEO David Cordani purchased 4,134 shares of the stock in a transaction dated Monday, November 3rd. The shares were bought at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer directly owned 157,935 shares in the company, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at $15,354,600. The trade was a 9.49% decrease in their position. The SEC filing for this sale provides additional information. 0.70% of the stock is owned by company insiders.
Cigna Group Trading Down 1.3%
Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business’s revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio is currently 26.64%.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on CI. Leerink Partners cut their price target on shares of Cigna Group from $300.00 to $270.00 in a report on Friday, October 31st. Sanford C. Bernstein cut their price target on Cigna Group from $346.00 to $294.00 and set a “market perform” rating on the stock in a research note on Wednesday, November 12th. Jefferies Financial Group reissued a “buy” rating and issued a $310.00 price objective on shares of Cigna Group in a research note on Monday, November 3rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Tuesday, November 25th. Finally, Robert W. Baird set a $372.00 price target on Cigna Group in a report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $334.05.
Cigna Group Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
- Five stocks we like better than Cigna Group
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
- Insider Trades May Not Tell You What You Think
- Congress Beat the Market Again—Here Are the 3 Stocks They Bought
- Using the MarketBeat Dividend Yield Calculator
- Go on a Shopping Spree With 3 Top Retail ETFs
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
